Literature DB >> 8616554

Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness.

I J Doull1, S Lawrence, M Watson, T Begishvili, R W Beasley, F Lampe, T Holgate, N E Morton.   

Abstract

To investigate genetic factors in asthma and atopy, we sought allelic associations for 12 markers near candidate loci for serum total, immunoglobulin E (IgE), and bronchial hyperresponsiveness (BHR) to inhaled histamine in 131 families comprising 685 individuals, selected randomly without regard to atopy or asthma. Nonparametric linkage and association analyses were performed with the Nonparametric Analysis of Lineage and Association (NOPAR) program, and parametric analyses were performed with the Complex Inheritance with Diathesis and Severity (COMDS) program on an ordered polychotomy of ranked scores. On chromosome 11q, allele 168 at the D11S527 locus was significantly associated with BHR (p<0.0003) but not with log IgE. At the D11S534 locus, allele 235 was significantly associated with log IgE (p = 0.007) but not with BHR. Both D11S527 and D11S534 were too distant from the gene encoding the high-affinity IgE receptor FcepsilonRIbeta to account for the association. At the interleukin-9 (IL-9) locus, the 118 allele showed significant association with serum total IgE (p<0.003) but not with histamine BHR. Parametric tests are more conservative, perhaps because they demand consistency with mendelian inheritance and tight linkage. These findings provide support for the view that both chromosomes 5 and 11 may contain genes relevant to asthma and atopy, a possible candidate being the interleukin-4 (IL-4) gene cluster. Because these associations are extremes in a large number of tests, they require confirmation in other samples.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616554     DOI: 10.1164/ajrccm.153.4.8616554

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  A second-generation genomewide screen for asthma-susceptibility alleles in a founder population.

Authors:  C Ober; A Tsalenko; R Parry; N J Cox
Journal:  Am J Hum Genet       Date:  2000-10-05       Impact factor: 11.025

Review 3.  Pathophysiological mechanisms of asthma. Application of cell and molecular biology techniques.

Authors:  K F Chung; I M Adcock
Journal:  Mol Biotechnol       Date:  2001-07       Impact factor: 2.695

4.  Genomewide screen and identification of gene-gene interactions for asthma-susceptibility loci in three U.S. populations: collaborative study on the genetics of asthma.

Authors:  J Xu; D A Meyers; C Ober; M N Blumenthal; B Mellen; K C Barnes; R A King; L A Lester; T D Howard; J Solway; C D Langefeld; T H Beaty; S S Rich; E R Bleecker; N J Cox
Journal:  Am J Hum Genet       Date:  2001-05-10       Impact factor: 11.025

Review 5.  Molecular biology and genetics of allergy and asthma.

Authors:  G G Anderson; J F Morrison
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

Review 6.  Associations of TIM-1 Genetic Polymorphisms with Asthma: A Meta-analysis.

Authors:  Xiaochuan Xie; Xiaohan Shi; Peng Chen; Li Rao
Journal:  Lung       Date:  2017-04-22       Impact factor: 2.584

7.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

8.  Associations between multiple environmental exposures and Glutathione S-Transferase P1 on persistent wheezing in a birth cohort.

Authors:  Kathy T Schroer; Jocelyn M Biagini Myers; Patrick H Ryan; Grace K LeMasters; David I Bernstein; Manuel Villareal; James E Lockey; Tiina Reponen; Sergey Grinshpun; Gurjit K Khurana Hershey
Journal:  J Pediatr       Date:  2008-10-31       Impact factor: 4.406

Review 9.  Th9 and allergic disease.

Authors:  Pejman Soroosh; Taylor A Doherty
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

10.  Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB.

Authors:  S B Early; P Huyett; K Brown-Steinke; L Borish; J W Steinke
Journal:  Genes Immun       Date:  2009-04-23       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.